Company developing MRSA test raises $1.9 million
An infectious disease test developer has raised $1.9 million in a series B financing round to advance its MRSA screening panel. It will also use the funds to develop its new molecular diagnostic panels to detect sepsis and gastrointestinal infections in hospitalized patients. Molecular Detection’s Detect Ready MRSA screening panel is currently marketed in Europe, […]